Sapporo Clinical Laboratory, Inc.

58
Hold
  • Market Cap: Micro Cap
  • Industry: Retailing
  • ISIN: JP3321100004
JPY
1,970.00
4 (0.2%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationCash Flow
Sapporo Clinical Laboratory, Inc. Cash flow Statement
Figures in Million
Consolidated Cash Flow Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
No of Months
12
12
12
12
12
12
Profit Before Tax
699.00
597.00
959.00
1,502.00
1,175.00
845.00
Adjustment
0.00
0.00
0.00
0.00
0.00
0.00
Changes In working Capital
-323.00
90.00
234.00
-92.00
-246.00
296.00
Cash Flow after changes in Working Capital
0.00
0.00
0.00
0.00
0.00
0.00
Cash Flow from Operating Activities
730.00
1,077.00
1,430.00
1,573.00
837.00
1,255.00
Cash Flow from Investing Activities
-1,240.00
-395.00
-409.00
-610.00
-3,148.00
-2,913.00
Cash Flow from Financing Activities
-525.00
-369.00
-347.00
-332.00
1,943.00
-51.00
Net Cash Inflow / Outflow
-1,035.00
312.00
673.00
629.00
-367.00
-1,709.00
Opening Cash & Cash Equivalents
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
0.00
0.00
0.00
0.00
0.00
Translation adjustment on reserves / op cash balances foreign subsidiaries
0.00
0.00
0.00
0.00
0.00
0.00
Effect of Foreign Exchange Fluctuations
0.00
0.00
0.00
0.00
0.00
0.00
Closing Cash & Cash Equivalent
0.00
0.00
0.00
0.00
0.00
0.00
Figures in JPY Million
Seasonal companies are compared with the same quarter last year
Compare Cash Flow Results of Sapporo Clinical Laboratory, Inc.
Markets Mojo
Figures in Million
consolidated Cash Flow Results
Markets Mojo
Markets Mojo
Change(JPY)
Change(%)
Profit Before Tax
699.777
1901.594
-1,202.00
-63.20%
Adjustment
0
0
0.00
0.00%
Changes In working Capital
-323.668
-801.656
478.00
59.63%
Cash Flow after changes in Working Capital
0
0
0.00
0.00%
Cash Flow from Operating Activities
730.911
1198.417
-468.00
-39.01%
Cash Flow from Investing Activities
-1240.168
-1134.731
-106.00
-9.29%
Cash Flow from Financing Activities
-525.743
-1027.981
502.00
48.86%
Net Cash Inflow / Outflow
-1035
-964.295
-71.00
-7.33%
Opening Cash & Cash Equivalents
0
0
0.00
0.00%
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0
0
0.00
0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations
0
0
0.00
0.00%
Translation adjustment on reserves / op cash balances foreign subsidiaries
0
0
0.00
0.00%
Effect of Foreign Exchange Fluctuations
0
0
0.00
0.00%
Closing Cash & Cash Equivalent
0
0
0.00
0.00%
Cash Flow - Snapshot (Consolidated) - Mar'25
stock-summary

YoY Growth in year ended Mar 2025 is -32.17% vs -24.66% in Mar 2024

Mar'25
Mar'24
Change(%)
Cash Flow from Operating Activities
730.91
1,077.59
-32.17%